<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001777631</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001771917</issuerCik>
      <issuerName>Karuna Therapeutics, Inc.</issuerName>
      <secFileNumber>001-38958</secFileNumber>
      <issuerAddress>
        <com:street1>99 HIGH STREET</com:street1>
        <com:street2>26TH FLOOR</com:street2>
        <com:city>BOSTON</com:city>
        <com:stateOrCountry>MA</com:stateOrCountry>
        <com:zipCode>02110</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>857-449-2244</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Brannan Stephen K.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Charles Schwab &amp; Co., Inc.</name>
        <address>
          <com:street1>3000 Schwab Way</com:street1>
          <com:city>Westlake</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>76262</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>5000</noOfUnitsSold>
      <aggregateMarketValue>1580662.00</aggregateMarketValue>
      <noOfUnitsOutstanding>37727117</noOfUnitsOutstanding>
      <approxSaleDate>02/08/2024</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>02/08/2024</acquiredDate>
      <natureOfAcquisitionTransaction>Employee Stock Option Exercise</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Karuna Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>5000</amountOfSecuritiesAcquired>
      <paymentDate>02/08/2024</paymentDate>
      <natureOfPayment>Broker Payment for Cashless Exercise</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Stephen K. Brannan</name>
        <address>
          <com:street1>99 HIGH STREET, 26TH FLOOR</com:street1>
          <com:city>BOSTON</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02110</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Karuna Therapeutics, Inc.</securitiesClassTitle>
      <saleDate>11/08/2023</saleDate>
      <amountOfSecuritiesSold>5000</amountOfSecuritiesSold>
      <grossProceeds>889262.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Stephen K. Brannan</name>
        <address>
          <com:street1>99 HIGH STREET, 26TH FLOOR</com:street1>
          <com:city>BOSTON</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02110</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Karuna Therapeutics, Inc.</securitiesClassTitle>
      <saleDate>12/08/2023</saleDate>
      <amountOfSecuritiesSold>10000</amountOfSecuritiesSold>
      <grossProceeds>2023671.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Stephen K. Brannan</name>
        <address>
          <com:street1>99 HIGH STREET, 26TH FLOOR</com:street1>
          <com:city>BOSTON</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02110</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Karuna Therapeutics, Inc.</securitiesClassTitle>
      <saleDate>01/08/2024</saleDate>
      <amountOfSecuritiesSold>15000</amountOfSecuritiesSold>
      <grossProceeds>4752164.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>02/08/2024</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>04/14/2023</planAdoptionDate>
      </planAdoptionDates>
      <signature>Stephen K. Brannan</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4764}]
144
0001777631
XXXXXXXX
LIVE
0001771917
Karuna Therapeutics, Inc.
001-38958
99 HIGH STREET
26TH FLOOR
BOSTON
MA
02110
857-449-2244
Brannan Stephen K.
Officer
Common
Charles Schwab & Co., Inc.
3000 Schwab Way
Westlake
TX
76262
5000
1580662.00
37727117
02/08/2024
NASDAQ
Common
02/08/2024
Employee Stock Option Exercise
Karuna Therapeutics, Inc.
N
5000
02/08/2024
Broker Payment for Cashless Exercise
N
Stephen K. Brannan
99 HIGH STREET, 26TH FLOOR
BOSTON
MA
02110
Karuna Therapeutics, Inc.
11/08/2023
5000
889262.00
Stephen K. Brannan
99 HIGH STREET, 26TH FLOOR
BOSTON
MA
02110
Karuna Therapeutics, Inc.
12/08/2023
10000
2023671.00
Stephen K. Brannan
99 HIGH STREET, 26TH FLOOR
BOSTON
MA
02110
Karuna Therapeutics, Inc.
01/08/2024
15000
4752164.00
02/08/2024
04/14/2023
Stephen K. Brannan